The finding is promising for ag, biofuel, carbon sequestration and artificial energy.Read More
Tobacco continues to be the most widely used plant for pharmaceutical manufacture.Read More
Harnessing plants as ‘biofactories’ is more cost-effective, say scientists.Read More
A study on Vuse underscores the contribution vapor products can make toward THR, writes James Murphy.Read More
The fascinating workings of a widely misunderstood chemical. Read More
What is bad science, and why is there so much of it?Read More
David O’Reilly, director of scientific research at BAT, shares his views on the roles of science and nicotine in tobacco harm reduction.Read More
Politics and data in tobacco harm reductionRead More
Quitting vaping early but continuing to smoke was the most common pattern.Read More
More robust and diverse data will help researchers develop predictive risk factor tools.Read More
Recent Posts
- Brazil Volume Down, Earnings Up
- Vaping Tied to Reduced Smoking Prevalence
- FDA Almost Done Reviewing Mass Market Products: Report
- Russia: Share of Smokers Halved
- Azerbaijan Hikes Tobacco Taxes
- BAT Reports Results
- Kutsaga Releases Climate Resilient Seeds
- Tracking Legislation Advances in Philippines
- BAT Pays Fine in Nigeria
- Regulator Proposes Retail Licensing
- KT&G Volunteers Help With Harvest
- IQOS’ U.S. Launch Postponed
- Zimbabwean Cigarette Exports up by Half
- Smoke-free Product Sales Boost PMI Income
- Air Global Launches R&D Facility in Dubai